J. ERIC WAGONER

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Sonnet BioTherapeutics Holdings, Inc.

Filing Date Source Excerpt
2018-07-13 Eric Wagoner served as Managing Director and Head of High-Yield & Distressed Securities division of Source Capital Group and serves on the board of Argus Research Group.
2019-11-19 Eric Wagoner served as a Managing Director and Head of the High-Yield & Distressed Securities division of Source Capital Group and holds a BA in psychology and an MBA.

Data sourced from SEC filings. Last updated: 2026-02-03